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Summary
Objective: Growth factors can profoundly affect the behaviour of chondrocytes during expansion and subsequent growth in three-dimensional
(3-D) scaffolds. Prolonging such effects has stimulated investigation of the transfer of growth factor genes to chondrocytes. This study eval-
uated the effects of the monolayer expansion medium on the proliferation and cartilage matrix molecule synthesis of chondrocytes in 3-D pellet
culture and in type II collageneglycosaminoglycan (CG) scaffolds, and on ex vivo insulin-like growth factor-1 (IGF-1) gene transfer to articular
chondrocytes in monolayer. The possibility of transfecting cells in 3-D culture using CG scaffolds was also investigated and the resulting effect
of IGF-1 overexpression on glycosaminoglycan (GAG) biosynthesis in 3-D culture was assessed.
Methods: Two expansion media were compareddone that has been widely used for growing chondrocytes (Medium 1) and one that has been
found to increase chondrocyte proliferation rates and preserve the redifferentiation potential of monolayer-expanded chondrocytes when sub-
sequently placed in pellet cultures (Medium 2). Chondrocytes were expanded in monolayer culture and then 1) redifferentiated in 3-D culture,
or 2) infected with the IGF-1 gene in monolayer or in type II CG scaffolds.
Results: The cell count for ﬁrst passage chondrocytes was more than 3-fold higher when using Medium 2. In 3-D culture, cells expanded with
Medium 2 and seeded in CG scaffolds produced more total GAG/DNA and displayed more intense immunohistochemical staining for collagen
type II. Gene transfer and IGF-1 release kinetics from infected cells in monolayer were signiﬁcantly affected by the composition of the expansion
medium, the gene transfer method and time. IGF-1 gene transfer in CG scaffolds resulted in a 35-fold elevation in accumulated IGF-1 released
from transfected Medium 2-expanded chondrocytes over controls, and resulted in a 40% increase in accumulated GAG/DNA.
Conclusion: The composition of the expansion medium signiﬁcantly affects monolayer proliferation of adult canine chondrocytes, GAG syn-
thesis when the cells are subsequently grown in CG scaffolds, and ex vivo IGF-1 gene transfer.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Cartilage
Repair
SocietyIntroduction
Several studies have demonstrated that the growth of
certain cell types in three-dimensional (3-D) scaffolds for ar-
ticular cartilage tissue engineering can enhance matrix syn-
thesis and increase type II collagen production in vivo1e3.
These cell types include differentiated articular chondro-
cytes and chondroprogenitor cells derived from marrow,
periosteum, and perichondrium4. The advantage of using
chondrocytes obtained from articular cartilage as a cell
source is that they already express the desired phenotype
for articular cartilage repair and they have been shown to
have the ability to synthesize matrix containing type II colla-
gen and aggrecan4. These cells, however, are limited in sup-
ply for autologous transplantation and expansion in culture
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Received 3 November 2005; revision accepted 5 June 2006.12is necessary to obtain a number sufﬁcient for cartilage repair
procedures. Yet, it has been demonstrated that articular
chondrocytes lose their chondrocytic phenotype (viz., the
cells no longer display a rounded morphology or synthesize
cartilage-speciﬁc macromolecules such as collagen type II
and aggrecan) during in vitro expansion in monolayer5,6.
Although studies have shown that monolayer-expanded
chondrocytes can redifferentiate into the chondrocytic phe-
notype when introduced into a 3-D environment such as in
cell pellets7 or porous scaffolds7,8, the greater the number
of serial passages, the more ﬁbroblast-like chondrocytes
becomedproducing molecules such as collagen type I
and versican and losing their capability to redifferentiate
when put back into a 3-D environment9. Both the mono-
layer expansion medium and redifferentiation medium
(used in 3-D culture) have recently been shown to directly
inﬂuence the ability of chondrocytes to redifferentiate10,11.
Not only does a speciﬁc combination of growth factors in
the expansion medium affect chondrocyte proliferation and
differentiation, it also inﬂuences the chondrocytic potential
and ability to redifferentiate when transferred back into
a 3-D environment (cell pellets)11.03
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importance as supplements to the media used for mono-
layer expansion and redifferentiation of chondrocytes,
they have been shown to be useful stimulants for chondro-
genesis and enhanced biosynthesis for cartilage repair
strategies. A local and prolonged administration of insulin-
like growth factor-1 (IGF-1) in vivo or in vitro could signiﬁ-
cantly beneﬁt articular cartilage tissue regeneration, as the
IGF-1 recombinant protein has been shown to increase
chondrocyte proliferation, proteoglycan synthesis, type II
collagen synthesis, and chondrogenesis12. Administration
of the recombinant protein alone in vivo, however, may be
insufﬁcient for therapeutic results due to protein degrada-
tion or diffusion from the defect site. A promising alternative
for a prolonged, localized release combines tissue engi-
neering and gene therapy strategies involving ex vivo
gene transfer13. In this approach, cells could be transfected
in vitro with the genes for proteins that have been shown to
enhance differentiation and biosynthesis, and then immedi-
ately implanted in vivo so that the desired proteins can be
expressed over the time course of regeneration. In using
this strategy, the effect that the expansion medium has on
the gene transfer susceptibility of cells has never been
investigated.
Prior studies have conﬁrmed successful IGF-1 gene
transfer to chondrocytes in monolayer with both viral14,15
and nonviral16 techniques. These studies also demon-
strated that cells overexpressing IGF-1 can enhance chon-
drogenesis and biosynthesis of matrix molecules in
monolayer14 or when subsequently implanted in vivo15,16.
Prolonged expression of the protein from cells infected in
monolayer, however, may still be limited in vivo due to pos-
sible migration of these cells from the defect site. Localiza-
tion and maintenance of infected cells within the defect site
may be accomplished using 3-D scaffolds onto which
seeded cells can attach, migrate within, and proliferate. It
has been shown that nonviral gene transfer to cells may
also be enhanced by the stiffness of the substrate material
upon which the cells are grown17. Investigators in this study
speculated that the modulation of gene uptake by cells by
surface rigidity was due to the control over cell proliferation.
Furthermore, work by Xie et al.18 demonstrated that
transfection of cells in 3-D resulted in longer expression
times than two-dimensional (2-D) transfection. A type Ii
collagen-glycosaminoglycan type II CG scaffold has been
shown to promote biosynthesis and proliferation of seeded
adult articular chondrocytes in vitro19 and improve cartilage
repair in vivo3,20. Based on this prior work, the ability to
transfect cells seeded within a type II CG scaffold was
also investigated. Not only might the type II CG scaffold
be used to promote chondrogenesis and proliferation, but
it may also enhance gene transfer to cells seeded within
the scaffold prior to transfection.
There were three objectives in the present work: (1) to de-
termine the effects of two different expansion media (each
having different additives and growth factors) on the ability
of monolayer-expanded adult canine articular chondrocytes
to produce cartilage matrix molecules (viz., glycosaminogly-
can (GAG)) in cell pellets or when seeded in type II CG
scaffolds, (2) to determine if the expansion medium can
also have an effect on the gene transfer susceptibility of
adult articular chondrocytes using a plasmid containing
the IGF-1 gene, and (3) using the better of the two media,
to determine the possibility of transfecting cells in 3-D cul-
ture using CG scaffolds. Achieving these objectives will al-
low us to determine certain culture conditions that can favor
the subsequent chondrogenic potential and biosynthesis ofcells in 3-D culture and enhanced gene transfer to cells
either in monolayer or 3-D culture, for the ultimate purpose
of preparing constructs for implantation.
Materials and methods
TYPE II COLLAGEN SCAFFOLDS
Porous sheets of type II collagen were fabricated by
freeze-drying a porcine cartilage-derived slurry (Geistlich
Biomaterials, Wolhusen, Switzerland). Similar type II scaf-
folds have been reported in prior studies to have a porosity
of 89 2% (mean standard deviation) and a pore diame-
ter of 125 42 mm [Ref. 21].
The collagen sheetswere sterilizedandcross-linkedbyde-
hydrothermal treatment22. Nine-mm diameter disks (w3 mm
thick) were punched out and additionally cross-linked by
a 10 min carbodiimide treatment23 using an aqueous solution
of 14 mM 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride and 5.5 mM N-hydroxysuccinimide (EDAC;
Sigma Chemical Co., St. Louis, MO). Excess EDAC was re-
moved by rinsing in phosphate buffered saline (PBS). The
mechanical properties of EDAC-treated CG scaffolds have
been previously reported23.
CELL ISOLATION AND MONOLAYER CULTURE
Chondrocytes were isolated from the trochleae of the
knees (stiﬂe joints) from one adult mongrel dog (2e4 years
old). Cells from one animal were used in this study in order
to eliminate variability related to inter-animal differences.
The cells were obtained using a sequential digestion of pro-
nase (20 U/ml, 1 h) and collagenase (200 U/ml, overnight)
as previously described24. Isolated chondrocytes were
then split and suspended in either one of the following
expansion media:
(1) Medium 1: Dulbecco’s modiﬁed Eagle’s medium,
DMEM/F12 (Gibco Life Technologies, Carlsbad,
CA) supplemented with 10% (v/v) fetal bovine serum
(FBS, Hyclone Technologies, Logan, UT), 25 mg/ml
ascorbic 2-phosphate (Wako Chemical, Osaka,
Japan), and a penicillin/streptomycin/fungizone cock-
tail (Gibco).
(2) Medium 2: High glucose DMEM (4.5 g/l D-glucose,
without L-glutamine and with 1 mM sodium pyruvate)
containing 10% (v/v) FBS, 0.1 mM nonessential
amino acids, 10 mM N-2-hydroxyethylpiperazine-
N0-2-ethanesulfonic (HEPES) buffer, 100 U/ml
penicillin, 100 mg/ml streptomycin glutamate, and
supplemented with the following growth factors (all
from R&D Systems, Minneapolis, MN): 5 ng/ml of ﬁ-
broblast growth factor-2 (FGF-2), 10 ng/ml of plate-
let-derived growth factor-bb (PDGF-bb), and 1 ng/ml
of transforming growth factor-b1 (TGF-b1).
Medium 1 used in the present investigation was one that
has been widely used as an expansion medium for growing
chondrocytes in monolayer, while Medium 2 has been
found in a prior study11 to increase chondrocyte proliferation
and preserve the redifferentiation potential of expanded
chondrocytes when subsequently placed in pellet cultures.
Primary chondrocytes were plated in 6-well culture plates
at 250,000 cells/well (w8-cm2 per well) for proliferation
studies and in 75-cm2 ﬂasks at 2 million cells/ﬂask for ex-
pansion and use in 3-D culture or in monolayer gene trans-
fer studies. The cells were incubated at 37(C and 5% CO2.
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nized, resuspended, and re-plated to obtain P1 cells.
CELL PROLIFERATION AND MORPHOLOGY IN MONOLAYERS
The cell counts for conﬂuent monolayers of P0 and P1
chondrocytes were obtained by counting the cells (by he-
macytometry) at conﬂuence in 6-well plates with an initial
plating density of 250,000 cells/well. The total cell number
at conﬂuence was used for comparison in order to incorpo-
rate the effects of the media on both cell attachment to
tissue culture plates and cell proliferation.
CULTURE OF CELL PELLETS AND CELL-SEEDED COLLAGEN
SCAFFOLDS
A portion of P0 chondrocytes from the two different ex-
pansion media cultures were either spun down to obtain
cell pellets or seeded into the porous type II collagen scaf-
folds using a static seeding method. Cell pellets were ob-
tained by spinning 5 105 cells in 1.5 ml polypropylene
conical tubes at 4500 rpm for 30 s. For collagen type II scaf-
folds, scaffolds were pre-wet with serum-free medium
(SFM) and placed on agarose-coated wells. Two million
cells were added to each scaffold by pipetting a suspension
of 1 million cells (in 20 ml medium) onto each side with a
10-min incubation period in between. By this static seeding
method approximately 1.6 million chondrocytes have been
found to attach to the scaffolds.
While the cells were expanded in two different culture
media, the cell pellets and the cell-seeded scaffolds were
cultured in the same deﬁned SFM, found in previous
work11 to enhance differentiation. The SFM consisted of
high glucose DMEM (4.5 g/l D-glucose, without L-glutamine
and with 1 mM sodium pyruvate), 0.1 mM nonessential
amino acids, 10 mM HEPES buffer, 100 U/ml penicillin,
100 mg/ml streptomycin glutamate, ITSþ1 (100, by Sigma
Chemical, St. Louis, MO), 0.1 mM ascorbic 2-phosphate,
1.25 mg/ml bovine serum albumin, 10 ng/ml of TGF-b1,
and 100 nM dexamethasone. Medium was changed every
2e3 days (0.5 ml for pellets and 0.8 or 1.5 ml for scaffolds).
Cultures were terminated after 2 weeks for histological
evaluation and biochemical analysis. For DNA and GAG
analyses, pellets and scaffolds were lyophilized and enzy-
matically digested using proteinase K (Roche Diagnostics,
Indianapolis, IN).
HISTOLOGY AND IMMUNOHISTOCHEMISTRY OF CELL
PELLETS AND CELL-SEEDED SCAFFOLDS
Cell pellets (n¼ 2) and cell-seeded scaffolds (n¼ 2) were
ﬁxed in 10% neutral buffered formalin, dehydrated, embed-
ded in parafﬁn, and sectioned (8 mm thick) by microtomy.
Sections were stained with Hematoxylin and Eosin to deter-
mine cell morphology and distribution and Safranin-O for
sulfated GAG. Total collagen content was revealed with
Masson’s trichrome stain. Immunohistochemistry was per-
formed to identify type I and type II collagens. Mouse anti-
chick monoclonal antibody for type II collagen was obtained
from the Developmental Studies Hybridoma Bank (Iowa
City, IA) and used at a dilution of 1:20 for 30 min. The
antibody for type I collagen was obtained from Sigma
(St. Louis, MO) and used at a 1:200 dilution for 60 min. For
immunohistochemical analysis, sections were enzymatically
digested by protease type XIV for 40e45 min and stained
with a standard avidinebiotin complex peroxidase-basedantibody staining technique (Vectastain, Vector Laborato-
ries, Burlingame, CA).
MONOLAYER INFECTION
P0 chondrocytes expanded in both types of media were
plated in 24-well plates (w30,000 cells/cm2) for gene trans-
fer studies. At conﬂuence, the cell monolayers were rinsed
with PBS and incubated with either an aliquot of lipid-medi-
ated transfection reagent (GenePorter (GP), Gene Ther-
apy Systems, Inc., San Diego, CA) complexed to the
plasmid encoding for IGF-1 or with the adenovirus
(ad)IGF-1 vector (both vectors supplied by the Center for
Orthopaedic Molecular Biology and Gene Therapy at the
Brigham and Women’s Hospital. An 8:1 (v/w) ratio of trans-
fection reagent to IGF-1 plasmid per well was used for non-
viral transfections. For viral transductions, 100 106 viral
particles were added to each well. Three hours later, the
vector solutions were removed from cultures and replaced
with 0.5 ml of SFM. SFM was used during gene transfer
and throughout the 2-week culture period during which me-
dium was collected and changed every 2e3 days after in-
fection. A sandwich enzyme-linked immunosorbent assay
(ELISA) kit for the human IGF-1 protein (R&D Systems)
was used to detect the amount of IGF-1 in the medium
(n¼ 3), which reﬂected the effect of the expansion medium
on vector uptake by cells, transfection efﬁciency, and sub-
sequent release of the growth factor. For the ultimate pur-
pose of employing the monolayer-expanded cells in
constructs for implantation, it is the amount of growth factor
released that is the principal measure and not necessarily
the transfection efﬁciency. It may be that only a few trans-
fected cells are needed to produce meaningful therapeutic
levels of the growth factor.
NONVIRAL GENE TRANSFER IN 3-D CULTURE
Chondrocytes expanded in the medium that yielded the
more favorable results in the 3-D chondrogenic assays
and monolayer transfection experiments (which proved to
be Medium 2) were seeded onto the type II CG scaffolds
as described above. Two hours after seeding, the cells
seeded in the scaffolds were transfected nonvirally by
submerging the construct in a solution containing plasmid
IGF-1 (pIGF-1) complexed with the GP transfection reagent
using an 8:1 ratio (v/w) of GP:pIGF-1. Four micrograms of
plasmid was used for each scaffold (n¼ 3). Two hours later,
the cell-seeded scaffolds were transferred onto agarose-
coated wells and 0.8 ml of SFM was added to each well.
The controls cultured in parallel were cell-seeded scaffolds
without the addition of plasmid.
Over a 2-week culture period, medium was collected from
the 3-D cultures at various time points and assayed for IGF-
1 using the human IGF-1 sandwich ELISA kit (R&D Sys-
tems, Minneapolis, MN). Less medium was used for these
3-D cultures (0.8 ml/scaffold vs 1.5 ml/scaffold for the chon-
drogenic assays) in order to concentrate the IGF-1 released
in the medium. At the end of the culture period, scaffolds
were lyophilized and enzymatically digested using protein-
ase K for DNA and GAG analyses.
DNA ANALYSIS
The DNA content of cell pellets and cell-seeded scaffolds
was measured using the Hoechst 33258 dye method25
(n¼ 3e4). A 50 ml aliquot of the proteinase K digest mixed
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10 mM Tris, 1 mM Na2EDTA and 0.1 M NaCl, pH 7.4) was
assayed ﬂuorometrically. The results were extrapolated
from a standard curve established using calf thymus DNA.
GAG ANALYSIS
The sulfated GAG content of cell pellets and cell-seeded
scaffolds was determined by the dimethylmethylene blue
(DMMB) dye assay26 (n¼ 3e4). A 100 ml aliquot of the pro-
teinase K digest was mixed with 2 ml of the DMMB dye and
the absorbance at 525 nm was measured with a spectro-
photometer. The results were obtained by extrapolating
from a standard curve using shark chondroitin-6-sulfate.
Newly accumulated GAG was determined by subtracting
the unseeded values from the sample values.
STATISTICAL ANALYSIS
Data were analyzed by one, two, three-factor analysis of
variance (ANOVA), and Fisher’s PLSD post hoc testing us-
ing StatView (SAS Institute Inc, Cary, NC). Data are pre-
sented as mean standard error of the mean (S.E.M.).
Results
PROLIFERATION OF MONOLAYER CULTURES
There were signiﬁcant differences in the cell counts for
P0 and P1 chondrocytes expanded in monolayer using
the two types of media (Fig. 1). The cell counts for P0
and P1 chondrocytes grown in Medium 1 were 2.3 mil-
lion 0.2 and 2.5 million 0.1, respectively, whereas, cell
counts for chondrocytes grown in Medium 2 were 2.7 mil-
lion 0.2 for P0 and 8.3 million 0.3 for P1 cells. P1 cells
expanded in Medium 2 showed more than a 3-fold higher
cell number compared to cells grown in Medium 1 after 4
days (Fig. 1). Two-factor ANOVA revealed a signiﬁcant ef-
fect of the expansion medium (P< 0.001; power¼ 1.00)
and passage number (P< 0.001; power¼ 1.00) on the pro-
liferation of chondrocytes in monolayer culture.
CELL MORPHOLOGY OF CHONDROCYTE MONOLAYERS
Morphological differences of cells grown in the two differ-
ent expansion media were observed by light microscopy
[Fig. 2(a and b)]. Chondrocytes expanded in Medium 1
Fig. 1. Cell counts of chondrocyte monolayers grown in Medium 1
or Medium 2. P0 cells were cultured for 120 h and P1 cells were
cultured for 96 h. Error bars represent S.E.M.; n¼ 5e6.[Fig. 2(a)] were larger and cell vacuoles were more visible
compared to those expanded in Medium 2 [Fig. 2(b)]. Fur-
thermore, when using Medium 2, there were a signiﬁcant
number of cells that had a rounded morphology [Fig. 2(b)]
instead of the ﬁbroblast-like elongated morphology that is
usually seen during monolayer expansion of chondrocytes.
APPEARANCE AND BIOCHEMICAL ANALYSIS OF THE CELL
PELLETS AND CELL-SEEDED CG SCAFFOLDS
Over the 2-week culture period the cell pellets slightly
increased in size to a ﬁnal maximum diameter of approxi-
mately 1.5 mm. The cell-seeded CG scaffolds contracted
only slightly from their original diameter of 9 mm. Of note
was the disc-like shape of the pellets that was maintained
throughout the culture period (pellets did not contract to
become more spherical in shape). There were no statistically
signiﬁcant differences in DNA and total GAG contents for cell
pellet cultures prepared with cells expanded in either type of
media. The DNA contents of cell pellets for chondrocytes
expanded in Medium 1 and Medium 2 were 2.2 0.1 mg and
2.4 0.1 mg, respectively. The GAG contents of these pellets
were 84.7 2.1 mg for Medium 1-expanded cells and
83.2 2.8 mg for Medium 2-expanded cells.
In contrast to the results from the pellet assay, the GAG/
DNA contents of the CG scaffolds seeded with cells ex-
panded in Medium 2 were signiﬁcantly higher than values
from constructs prepared with Medium 1-expanded cells
(Fig. 3). There was also a noticeable effect of the amount
of medium added per scaffold. For both types of medium,
1.5 ml added per scaffold produced 40e50% higher GAG/
DNA values compared to adding 0.8 ml of medium per scaf-
fold. Scaffolds seeded with cells expanded in Medium 2
showed a 20e40% increase in GAG/DNA produced com-
pared to cells expanded in Medium 1. Two-factor ANOVA
revealed a signiﬁcant effect of both expansion medium
and amount of medium on GAG/DNA values (P< 0.0001;
power¼ 1.00).
HISTOLOGY AND IMMUNOHISTOCHEMISTRY
OF 3-D CULTURES
Histology revealed that chondrocytes expanded in both
types of medium produced cartilaginous constructs when
cultured as cell pellets for 2 weeks (Fig. 4). Most of the cells
displayed a rounded morphology and appeared in lacunae
[Fig. 4(b and c)], consistent in appearance with the distin-
guishing cellular features of hyaline cartilage. Cells near
the surface of all pellets assumed a more elongated appear-
ance, with a lower percentage contained within lacunae.
Some areas near the pellet surface were completely devoid
of cells [Fig. 4(b and c)].
A continuous extracellular matrix rich in GAG was clearly
demonstrated in the histochemical sections of pellets
prepared with the cells expanded in either type of media, re-
vealed by the intense staining with Safranin-O [Fig. 4(def)].
In some pellets, however, the surface zone (approximately
50 mm thick) devoid of cells, displayed little staining for
GAGs [Fig. 4(e)]. Masson’s trichrome staining of the pellets
revealed collagen concentrated on the periphery of the cell
pellets, and more diffuse in the majority of the center region
for both groups [Fig. 4(jel)]. Immunohistochemical staining
of type II collagen [Fig. 4(gei)] was evident for both types
of expansion media. Qualitatively, there was more intense
type II collagen staining in sections of pellets prepared
with cells expanded in Medium 2 [Fig. 4(i)] compared to pel-
lets prepared with cells expanded in Medium 1 [Fig. 4(h)].
1207Osteoarthritis and Cartilage Vol. 14, No. 12Fig. 2. Light micrographs (phase contrast) of P1 chondrocyte monolayers grown in (a) Medium 1 or (b) Medium 2 at conﬂuence (5 days).Although the GAG distribution in pellets was generally uni-
form throughout (except in the surface zone), the distribu-
tion of type II collagen staining generally was more
intense on the outer periphery of the pellets and more dif-
fuse in the center [Fig. 4(g)]. Type I collagen staining of
the pellets was generally negative. However, some Mas-
son’s trichrome-positive areas that did not stain for type II
collagen would have been expected to be positive for type
I collagen. This fact along with the ﬁnding that other type I
collagen-containing tissues processed at the same time
failed to stain with the antibody, led us to disregard the
type I immunohistochemistry results. Based on positive
Masson’s trichrome staining and negative type II immuno-
histochemistry, type I collagen appeared to be present
both in peripheral and in central regions of pellets.
The cell density in the chondrocyte-seeded CG scaffolds
was markedly less than in the cell pellets. A lower percent-
age of cells in the collagen scaffolds displayed the cho-
ndrocytic morphology compared to the pellets, with no
noticeable effect of expansion medium [Fig. 5(b and c)].
For cell-seeded CG scaffolds, chondrocytes expanded in
Medium 2 showed more areas of GAG accumulation within
the scaffolds compared to cells expanded in Medium 1
[Fig. 5(e and f)]. Chondrocyte-seeded scaffolds in both
groups also stained positive for total collagen throughout
the scaffolds [Fig. 5(k and l)] and more speciﬁcally for
type II collagen, with stronger staining found in areas
Fig. 3. GAG/DNA content of chondrocyte-seeded CG scaffolds
(2-week culture) for chondrocytes expanded in Medium 1 or
Medium 2 with either 0.8 ml or 1.5 ml of media added per well. Error
bars indicate standard error.surrounding cells [Fig. 5(h and i)]. The intensity of the
type II staining throughout the samples indicated the clear
predominance of type II collagen. It is important to note
that although the scaffold itself is made up of type II colla-
gen, the processing of the collagen material for scaffold fab-
rication somehow alters the type II collagen so that it does
not stain positive in type II collagen immunohistochemical
staining (veriﬁed by staining unseeded scaffold samples).
Therefore, positive staining for type II collagen in these
cell-seeded scaffolds is most likely a reﬂection of newly syn-
thesized type II collagen. As demonstrated in the cell pel-
lets, cells expanded in Medium 2 showed more intense
staining for type II collagen in the scaffolds compared to
cells expanded in Medium 1 [Fig. 5(h and i)].
IGF-1 SYNTHESIS IN MONOLAYER CULTURES
Control monolayers did not display any IGF-1 release into
the medium. In contrast, IGF-1 protein release reﬂecting
gene transfer was observed for all transfected or transduced
monolayers (Fig. 6). GP/pIGF-1 transfection of monolayers
grown with both media formulations demonstrated substan-
tially greater IGF-1 release within the ﬁrst 7 days of culture
[Fig. 6(a)]. The peak of IGF-1 release for transfected cells
expanded in the Medium 2, however, occurred earlier (day
2) than the peak release for cells expanded with Medium 1
(day 5). After the peak, IGF-1 release for these monolayers
showed a general drop at day 7 followed by a gradual de-
crease in IGF-1 production until minimal expression was de-
tected in the day-12 collection. Monolayers transduced with
adIGF-1 demonstrated a different IGF-1 release proﬁle com-
pared to transfected monolayers [Fig. 6(b)]. Substantial ex-
pression for both transduced monolayers was not detected
until the collection at day 5, and both showed similar release
proﬁles up to day 9. Thereafter, cells expanded in Medium 2
showed a noticeably higher IGF-1 release over monolayers
expanded with Medium 1 (days 12 and 14). In contrast to
transfected monolayers, transduced monolayers showed
a signiﬁcantly lower IGF-1 expression at the early collec-
tions, but maintained a more steady release of IGF-1 (no sig-
niﬁcant peak) over the 2-week culture. Although infection
conditions were not optimized for either gene transfer
method in this study, the kinetics of gene expression for
transfected and transduced monolayers appear to corre-
spond with the general trend associated with these types
of infection methods.
Three-factor ANOVA demonstrated signiﬁcant effects
of expansion medium (P¼ 0.02; power¼ 0.63), method
1208 R. M. Capito and M. Spector: Effect of expansion medium in type II CG scaffoldsFig. 4. Histology and immunohistochemistry of chondrocyte pellets (2-week culture) for cells expanded in Medium 1 (second column) or Me-
dium 2 (third column) and redifferentiated in SFM. Sections were stained with Hematoxylin and Eosin (aec) to show cell morphology and dis-
tribution, with Safranin-O (def) for GAGs (red is positive stain), and Masson’s trichrome (jel) for collagen content (blue stains collagen, red
stains cytoplasm). Sections were also immunohistochemically stained for type II collagen (gei, brown is positive stain). Lower magniﬁcation
micrographs to demonstrate staining distribution representative of both groups are shown in the ﬁrst column (a & d are samples from the
Medium 2 group and g & j are samples from the Medium 1 group).of gene transfer (P< 0.0001; power¼ 1), and time
(P< 0.0001; power¼ 1) on IGF-1 release in the medium
over the 2-week period. While the effect of expansion me-
dium in the three-factor ANOVA had only a moderate power
(0.63), subsequent Fisher’s PLSD post hoc test demon-
strated a highly signiﬁcant difference between Medium 1
and Medium 2 (P< 0.0001). In order to more fully examine
statistical differences between these two types of media,
one-factor ANOVA was performed for each time point
and gene transfer method comparing the two media types.Statistically signiﬁcant differences in IGF-1 release between
Medium 1 and Medium 2 for GP transfected monolayers
occurred at day 2 (P< 0.0001; power¼ 1), day 5 (P¼
0.0005; power¼ 1), and day 7 (P¼ 0.0004; power¼ 1).
Signiﬁcant differences for transduced monolayers were
seen at day 2 (P< 0.0001; power¼ 1), day 5 (P¼ 0.0012;
power¼ 1), day 7 (P¼ 0.0212; power¼ 0.711), and day
14 (P¼ 0.0004; power¼ 1).
Of signiﬁcance is that the accumulated amount of IGF-1
reached a therapeutic level (e.g., 50e100 ng/ml [Ref. 12])
1209Osteoarthritis and Cartilage Vol. 14, No. 12Fig. 5. Histology and immunohistochemistry of chondrocyte-seeded CG scaffolds (2-week culture) for cells expanded in Medium 1 (second
column) or Medium 2 (third column) and redifferentiated in SFM. Sections were stained with Hematoxylin and Eosin (aec) to show cell mor-
phology and distribution, with Safranin-O (def) for GAGs (red is positive stain), and Masson’s trichrome (jel) for collagen content (blue stains
collagen, red stains cytoplasm and residual scaffold struts). Sections were also immunohistochemically stained for type II collagen (gei, brown
is positive stain). Lower magniﬁcation micrographs to demonstrate staining distribution representative of both groups are shown in the ﬁrst
column (samples are from the Medium 1 group).for both gene transfer methods over the 2-week period.
Moreover, this therapeutic level was reached by a nonviral
gene transfer method only 5 days after transfection.
NONVIRAL IGF-1 GENE TRANSFER IN CG SCAFFOLDS
AND EFFECTS ON BIOSYNTHESIS
IGF-1 gene transfer to Medium 2-expanded chondrocytes
in type II CG scaffolds resulted in a substantial elevation of
IGF-1 synthesis over the non-transfected control group(Fig. 7). Chondrocytes grown in type II CG scaffolds without
treatment with the plasmid (controls) produced only minute
amounts of IGF-1 in the medium with a total accumulation of
about 600 pg over the 2-week culture (Fig. 7). There was,
however, evidence of a slight increase in IGF-1 production
at the end of the 2-week period for these control scaffolds.
Transfected 3-D cultures showed a 35-fold higher elevation
in accumulated IGF-1 collected in the medium over the 2-
week culture compared to control scaffolds. For transfected
cultures, there was a peak release of IGF-1 in the medium
1210 R. M. Capito and M. Spector: Effect of expansion medium in type II CG scaffoldsat about a week (w7.5 ng/ml), after which IGF-1 release
started to slightly decline (Fig. 7).
IGF-1 overexpression by chondrocytes grown in type II
CG scaffolds resulted in a signiﬁcant increase of GAG/
DNA synthesis over control scaffolds. There was a 40%
higher GAG/DNA value for IGF-1 transfected cultures com-
pared to the control group (Fig. 8); the control group is the
same as the 0.8 ml, Medium 2 group in Fig. 3. One-factor
Fig. 6. IGF-1 protein production detected in the collected media
samples of adult canine chondrocyte monolayer cultures grown in
Medium 1 or Medium 2 transfected with pIGF-1 and GP reagent
(a) or transduced with adIGF-1 (b). n¼ 3; mean  S.E.M. (error
bars hidden by symbols). IGF-1 amounts for control cultures are
on the zero axis.
Fig. 7. IGF-1 protein production detected in the collected media of
chondrocytes expanded in Medium 2 and seeded in collagen type II
CG scaffolds, with or without subsequent transfection with GP/
pIGF-1. n¼ 3; mean S.E.M.ANOVA revealed a signiﬁcant effect of IGF-1 overexpres-
sion on GAG/DNA (P< 0.0001; power¼ 1).
Discussion
The current investigation demonstrated that the medium
used in expanding chondrocytes in monolayer has a signiﬁ-
cant inﬂuence on GAG synthesis and chondrogenesis when
chondrocytes are subsequently grown in a tissue engineer-
ing scaffold comprised of collagen (type II)-GAG. As
in previous work11, addition of speciﬁc growth factors within
the expansion medium signiﬁcantly increased proliferation
of chondrocytes in monolayer. The cell morphology, which
is one indicator that can deﬁne a chondrocyte phenotype,
was also affected. At conﬂuence, cultures grown in Medium
2 were made up of chondrocytes that were smaller and that
possessed a rounded morphology (characteristic of a
chondrocytic phenotype) compared to cultures grown in
Medium 1. The smaller cell size of chondrocytes expanded
in the Medium 2 may be a result of a greater number of cells
present at conﬂuence. Using Medium 2 resulted in a more
than 4-fold difference in cell number for P1 cells at conﬂu-
ence. This may be advantageous for decreasing the time
needed to obtain a sufﬁcient number of cells for preparation
of tissue-engineered articular cartilage constructs for
implantation.
Pellet cultures yielded the characteristic small diameter
spheroids that contained high levels of GAG and type II col-
lagen. The small diameters of these cell pellets, however,
render these constructs undesirable for implantation. There
was no signiﬁcant difference in the total GAG accumulated
within cell pellets for chondrocytes expanded in Medium 1
compared to Medium 2. That the total GAG values may
have been at maximum levels achieved in the pellet cultures,
may explain why there were no detectable differences in pel-
lets comparing the two expansion media. Despite this unde-
tectable difference in GAG, more intense collagen type II
stainingwas present with chondrocytes expanded inMedium
2, demonstrating greater chondrogenesis in these pellets.
There was a more prominent difference in the effects of
expansion media when P1 chondrocytes were grown in
CG scaffolds, compared to the pellet assay. The expansion
medium demonstrated a signiﬁcant effect on DNA, total
GAG accumulation, and GAG/DNA content when chondro-
cytes were seeded in CG scaffolds and cultured in SFM for
2 weeks. Furthermore, a greater number of areas that
Fig. 8. GAG/DNA (2-week cultures) of type II CG scaffolds seeded
with chondrocytes expanded in Medium 2, with or without subse-
quent transfection with GP/pIGF-1. n¼ 3; mean S.E.M.
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for constructs seeded with chondrocytes expanded in
Medium 2. A notable ﬁnding was the signiﬁcantly higher
amount of total GAG accumulation and GAG staining within
cell pellets compared to cell-seeded CG scaffolds. It is
speculated that this difference between cell pellet and scaf-
fold culture may be related to the effects of cell densitydcell
pellets having a greater concentration of cells compared to
the seeded scaffolds. Prior work investigating the chon-
droinduction of mesenchymal stem cells in pellet cultures
has also supported an association between increasing cell
density from pellet contraction, and chondrogenesis27. In
the present investigation, areas within scaffolds that ap-
peared to have a higher cell density displayed more staining
for GAG. Within cell pellets, where the cell density was uni-
formly high throughout, there was a continuous matrix rich
in GAG. It is also possible that the porosity of the scaffold
itself may allow for diffusion of GAGs from the scaffold
into the medium, as seen in a prior study23, making it
more difﬁcult for GAG to accumulate within the scaffold (ap-
parent in the weak staining for Safranin-O). The tighter
packing of cells within cell pellets may facilitate GAG accu-
mulation, demonstrated in the more intense and uniform
Safranin-O staining.
Chondrocyte-seeded CG scaffolds, demonstrated colla-
gen synthesis and showed evidence of chondrogenesis
with positive staining for type II collagen throughout the scaf-
folds. Although there did not seem to be a noticeable differ-
ence between groups in the amount of tissue that stained
for overall collagen (with Masson’s trichrome), there was
more intense staining of type II collagen within CG matrices
that incorporated cells expanded in Medium 2, suggesting
that more articular cartilage-speciﬁc matrix molecules may
be produced by these cells compared to ones expanded in
Medium 1. The type I collagen staining results in the present
study were unreliable. This may have been due to overﬁxa-
tion of the samples since the type I antibody seems to be
very sensitive to sample ﬁxation. The presence of type I, how-
ever, could be deduced from comparing the Masson’s
trichrome and type II immunohistochemical sections.
The varied morphology (including the presence/absence
of lacunae) indicated that there was phenotypic heterogene-
ity in the cell populations within CG scaffolds and pellets.
Moreover the absence of type II collagen staining in Mas-
son’s trichrome-positive regions indicated that some cells
were producing non-cartilaginous matrix molecules (includ-
ing collagen types other than type II). In the context of the ob-
jective to produce constructs to facilitate cartilage repair
in vivo, future animal studies will be required to determine
to what extent this heterogeneity in cell phenotype affects
cartilage repair. After 2 weeks in in vitro culture, the presence
of type II collagen serves as an indication that at least some
of the cells are proceeding down the path of chondrogenesis.
A signiﬁcant ﬁnding of this study was that viral and non-
viral transgene expression levels of chondrocytes in mono-
layer were directly affected by the medium used to expand
the cells. For transduced monolayers, the effect that the
expansion medium had on IGF-1 release was not signiﬁ-
cant until the later collection periods (days 12 and 14)
where IGF-1 release from cells expanded in Medium 2
had signiﬁcantly higher levels than those expanded in
Medium 1. For transfected cells, monolayers expanded in
Medium 2 demonstrated an earlier peak in IGF-1 synthesis
compared to cells expanded in Medium 1. This earlier peak
in protein synthesis may indicate that the cells expanded in
Medium 2 were more receptive to nonviral gene transfer.
This enhanced receptiveness allowed therapeutic levels ofIGF-1 to be accumulated in vitro sooner (in 2 days) than
with cultures of chondrocytes grown in Medium 1.
Transfection efﬁciency was not determined in these stud-
ies because the ultimate goal is to use a gene encoding
a functional protein (IGF-1) for articular cartilage repair,
we evaluated the difference in the amount of IGF-1 released
in the medium using the different expansion media. It would
be interesting in future studies to verify the effects of me-
dium composition directly on transfection efﬁciency with
the use of reporter genes. It is speculated that the en-
hanced nonviral gene transfer after expansion using Me-
dium 2, may be due to an increased mitotic activity of the
cells as reﬂected in the proliferation data. During cell
division, disruption of the cell membrane and nuclear enve-
lope can facilitate gene uptake and transfer within the cell
nucleus. The greater number of cell divisions that resulted
when using Medium 2 for expansion, therefore, most likely
enhanced the transfection efﬁciency, leading to the in-
creased level of IGF-1 release particularly at the earlier
time points.
For in vivo applications, an earlier release of growth factor
may be advantageous in the ﬁrst stages of repair. The kinet-
ics of growth factor release, however, would most likely
require a prolonged and more sustained level to enhance
biosynthesis over the regeneration process, as opposed to
just a single peak of growth factor release at an early time
point. The end goal is to provide a prolonged release of
IGF-1 in vivo by implanting cells in a 3-D scaffold that are
overexpressing IGF-1. Three-dimensional scaffolds are
beneﬁcial to localize and retain the transfected cells and re-
leased growth factor within the defect site. Based on prior
studies18 demonstrating longer expression times for cells
transfected in 3-D compared to 2-D transfection, seeding
chondrocytes within the collagen scaffolds prior to transfec-
tion was another condition that was investigated in this study.
For simplicity, a monolayer assay was performed to deter-
mine if the type of expansion medium has a signiﬁcant
effect on the ability to infect chondrocytes with the IGF-1
gene. Because there was a beneﬁt to using Medium 2
for expansion with regard to subsequent gene transfer
in monolayer, Medium 2 was used to expand cells
when used for transfection in the collagen scaffolds.
Transfecting Medium 2-expanded chondrocytes after be-
ing seeded in type II CG scaffolds resulted in elevated
IGF-1 synthesis when compared to the controls. Interest-
ingly, chondrocytes seeded in 3-D scaffolds (without trans-
fection) showed some IGF-1 release in the medium, which
was more noticeable at the end of the 2-week period; as op-
posed to no detected IGF-1 expression in the monolayer
control cultures. This might indicate that the cell interaction
with the type II CG scaffold alone can potentially act as
a stimulus for IGF-1 expression. The IGF-1 release kinetics
from cells transfected in 3-D scaffolds also differed from that
of the transfected monolayer cultures. Transfected mono-
layer cultures showed a maximum release of IGF-1 at the
beginning of culture period and decreased signiﬁcantly
within a week. In contrast, IGF-1 levels in the medium
from transfected cell-seeded scaffolds showed a steadier
release proﬁle with a gradual increase up to about a week;
the cells displayed signiﬁcant IGF-1 overexpression until
the end of the 2-week period. This veriﬁes that using 3-D
scaffolds with gene transfer methods may provide a more
steady expression of desired growth factors in vitro and
in vivo over prolonged times.
In this study, a signiﬁcant increase in GAG biosynthesis
was associated with an overexpression of IGF-1 in cultures
of Medium 2-expanded cells that were transfected while
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work demonstrating that IGF-1 stimulates chondrocyte bio-
synthesis12. Future effort needs to investigate the biosyn-
thesis of other cartilage matrix molecules and histological
features of chondrogenesis. Of importance is that the actual
levels of IGF-1 localized within the scaffold could be signif-
icantly higher than the concentrations detected in the me-
dium. It would be interesting to investigate methods to
quantify IGF-1 expressed by cells that is retained within
the scaffold in order to determine the minimum local thera-
peutic concentration required to enhance chondrogenesis.
Of interest in the present study was the ﬁnding that the
volume of medium strongly affected GAG synthesis, with
a 40% increase in GAG/DNA in the cultures with 1.5 ml
compared to the cultures with 0.8 ml. The GAG/DNA from
the transfected chondrocytes in the CG scaffold in 0.8 ml
of medium was similar to the non-transfected cultures con-
taining 1.5 ml. A possible reason for this ﬁnding is that the
minimum amount of growth factors and nutrients needed
for optimal biosynthesis in these 3-D scaffolds was not
attained using just 0.8 ml of medium per scaffold. IGF-1
overexpression by transfected cells seeded in these scaf-
folds may have stimulated more GAG production. This dem-
onstrates the effectiveness of IGF-1 overexpression to
stimulate GAG production in less than optimal in vitro cul-
ture conditions. It is speculated that IGF-1 overexpression
by transfected cells may also have this beneﬁcial effect
in vivo where conditions are less controlled.
A limitation of this study is that cells from only one adult
animal were employed. As noted earlier, for this compara-
tive study, cells from one animal were used in order to elim-
inate variability related to inter-animal differences. Other
recent studies in our laboratory using adult canine chondro-
cytes from six animals in 8-mm diameter type II collagen
scaffolds showed that the coefﬁcient of variation of the
data for GAG accumulation was about 10%. The differ-
ences among groups in the current work were substantially
larger than would be expected with inter-animal variation.
This point notwithstanding, it would be helpful in future
work to investigate the effect of animal age on the sensitivity
of cells to the different expansion media with regard to
effects on proliferation, chondrogenic potential, and gene
transfer.
In conclusion, this study demonstrated that the expansion
medium used to grow chondrocytes has a signiﬁcant effect
on chondrocyte proliferation in monolayer, subsequent 3-D
culture using type II CG matrices, and ex vivo gene transfer.
Not only does Medium 2 decrease the amount of time it
takes to obtain a sufﬁcient number of cells for developing
tissue-engineered articular cartilage constructs, it also en-
hances gene transfer kinetics and improves the production
of matrix molecules and chondrogenesis when cells are
seeded within CG scaffolds.
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